Author

Takuma Shirasaka

OpenAlex ID: A5146655502

Switch to single-tablet bictegravir–lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial

2026 · Chloe Orkin, Chloe Orkin, et al. · The Lancet · 5

Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial

2026 · Amy E Colson, Princy N Kumar, et al. · The Lancet · 3

Works count: 2

Citation count: 8

H-index: 2

I10-index: